~~<i id='F3E9E58FEC'><strike id='F3E9E58FEC'><tt id='F3E9E58FEC'><pre id='F3E9E58FEC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：Wikipedia 2025-10-02 18:06:00 - browse：575

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

hotspot

knowledge

hotspot

leisure time

4:42Arainbowflagrepresentinggayprideispicturedhere.AlexanderSpatari/GettyImagesACaliforniaclothingst

WSS

PBMs are inflating the cost of generic drugs. They must be reined in

In his State of the Union, Biden takes clear aim at 'Big Pharma'

First medicine developed to treat MASH expected to be approved soon

Precocious puberty in girls comes with mental health risks

Intellia plays down concerns on accidental germline transmission

Wegovy improves function in certain heart failure patients

entertainment

Wikipedia

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CDC says it’s too soon to assess risk posed by Covid subvariant

BioMarin wins approval for gene therapy to treat hemophilia A

FDA advisory panel to debate high blood pressure devices

Sports medicine is finally prioritizing gender equality

In his State of the Union, Biden takes clear aim at 'Big Pharma'

At least 13 dead in Texas as scorching temps continue

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Psychedelics group wrestles with new pharma identity

DeSantis wants to import drugs. Biden’s FDA blasted his plan

hotspot

A deep dive into Applied Therapeutics’ data, and questions on Cassava

How the drug

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Can U.S. cancer drug shortages be fixed?

Hospital at home shows how to bring innovation to health care

Hospital at home shows how to bring innovation to health care

knowledge

knowledge

hotspot

leisure time